Search research articles
Contact Us
Filters
Showing results (11-20 of 162) with videos related to
Page
of 17
Sort By:
Journal of Clinical Medicine
|
November 27, 2024
Transforming Breast Cancer Care: Cutting-Edge Insights and Future Directions
Rita De Sanctis, Paola Tiberio, Alberto Zambelli, et al.
Experimental and Therapeutic Medicine
|
September 21, 2012
Absence of the K303R estrogen receptor α mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment
Chiara Ghimenti, Maurizia Mello-Grand, Lea Regolo, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia
|
March 29, 2012
[microRNAs as biological indicators of environmental and occupational exposure to asbestos]
Claudio Minoia, Elena Sturchio, Benedetta Porro, et al.
JCO Oncology Practice
|
January 9, 2026
Subcutaneous Immunotherapy in Cancer: Where We Are Now, What It Changes, and What to Watch Next
Fausto Petrelli, Alessandro Iaculli, Alberto Zambelli, et al.
Expert Opinion on Therapeutic Targets
|
May 31, 2022
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets
Alberto Zambelli, Riccardo Sgarra, Rita De Sanctis, et al.
Frontiers in Neurology
|
December 5, 2024
Commentary: Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel
Alessandro Viganò, Paola Tiberio, Nicholas Diani, et al.
BMC Bioinformatics
|
April 28, 2012
An ICT infrastructure to integrate clinical and molecular data in oncology research
Daniele Segagni, Valentina Tibollo, Arianna Dagliati, et al.
Cancers
|
January 8, 2023
Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast Cancer
Flavia Jacobs, Mariangela Gaudio, Chiara Benvenuti, et al.
Cancers
|
June 10, 2023
Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer
Flavia Jacobs, Elisa Agostinetto, Chiara Miggiano, et al.
Expert Opinion on Therapeutic Targets
|
September 24, 2020
Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer: learning from the past to design future strategies
Silvia Pegoraro, Gloria Ros, Michela Sgubin, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 162) with videos related to
Sort By:
Page
of 17
Journal of Clinical Medicine
|
November 27, 2024
Transforming Breast Cancer Care: Cutting-Edge Insights and Future Directions
Rita De Sanctis, Paola Tiberio, Alberto Zambelli, et al.
Experimental and Therapeutic Medicine
|
September 21, 2012
Absence of the K303R estrogen receptor α mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment
Chiara Ghimenti, Maurizia Mello-Grand, Lea Regolo, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia
|
March 29, 2012
[microRNAs as biological indicators of environmental and occupational exposure to asbestos]
Claudio Minoia, Elena Sturchio, Benedetta Porro, et al.
JCO Oncology Practice
|
January 9, 2026
Subcutaneous Immunotherapy in Cancer: Where We Are Now, What It Changes, and What to Watch Next
Fausto Petrelli, Alessandro Iaculli, Alberto Zambelli, et al.
Expert Opinion on Therapeutic Targets
|
May 31, 2022
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets
Alberto Zambelli, Riccardo Sgarra, Rita De Sanctis, et al.
Frontiers in Neurology
|
December 5, 2024
Commentary: Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel
Alessandro Viganò, Paola Tiberio, Nicholas Diani, et al.
BMC Bioinformatics
|
April 28, 2012
An ICT infrastructure to integrate clinical and molecular data in oncology research
Daniele Segagni, Valentina Tibollo, Arianna Dagliati, et al.
Cancers
|
January 8, 2023
Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast Cancer
Flavia Jacobs, Mariangela Gaudio, Chiara Benvenuti, et al.
Cancers
|
June 10, 2023
Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer
Flavia Jacobs, Elisa Agostinetto, Chiara Miggiano, et al.
Expert Opinion on Therapeutic Targets
|
September 24, 2020
Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer: learning from the past to design future strategies
Silvia Pegoraro, Gloria Ros, Michela Sgubin, et al.
Page
of 17